IMCD acquires US specialty pharmaceutical ingredient distributor Mutchler Inc. and Mutchler of Puerto Rico Inc.

ROTTERDAM, The Netherlands (1 July, 2016) – IMCD N.V. (“IMCD” or “Company”), a leading distributor of specialty chemicals, pharmaceutical and food ingredients, today announces that it has acquired 100% of Mutchler Inc. and Mutchler of Puerto Rico Inc. With a focus on the pharmaceutical market, Mutchler perfectly complements the existing IMCD US operations.

Mutchler is a leading specialty pharmaceutical ingredient distributor in the US and Puerto Rico with offices in Harrington Park, New Jersey and Puerto Rico. Mutchler is active in all US states and Puerto Rico and represents leading global pharmaceutical ingredient suppliers. In 2015, Mutchler generated revenue of USD 28 million and has approximately 30 employees.

Mutchler is an excellent fit with IMCD given their asset light business model and long term relationships with leading global suppliers. The acquisition supports the strategy of IMCD to become the leading global specialty chemicals distributor providing expertise and knowledge based formulation solutions to its customers.

Marcus Jordan, President of IMCD Holdings US Inc., commented: “Following the acquisition of MF Cachat (now IMCD US) in June 2015, this is an important next step as it expands our US operations into the pharmaceutical market, a strategic sector for IMCD. Mutchler has a reputation as a leading pharmaceutical ingredient supplier and we very much look forward to working together to further develop our offering to both suppliers and customers.”

Dwight Mutchler, President of Mutchler, adds: ”We are delighted to become part of IMCD as the alliance immediately propels Mutchler into the future with a larger and more specialized team and added technical know-how.”

For further information:

Investor Relations
T: +31 10 290 86 84